Zoonotic Viral Diseases of Equines and Their Impact on Human and Animal Health

Balvinder Kumar*, Anju Manuja, BR Gulati, Nitin Virmani, B.N. Tripathi
ICAR-National Research Centre on Equines, Hisar-125001, India

© 2018 Kumar et al.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: ( This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

* Address correspondence to this author at the ICAR-National Research Centre on Equines, Hisar-125001, India; Tel: +9466128008; E-mail:



Zoonotic diseases are the infectious diseases that can be transmitted to human beings and vice versa from animals either directly or indirectly. These diseases can be caused by a range of organisms including bacteria, parasites, viruses and fungi. Viral diseases are highly infectious and capable of causing pandemics as evidenced by outbreaks of diseases like Ebola, Middle East Respiratory Syndrome, West Nile, SARS-Corona, Nipah, Hendra, Avian influenza and Swine influenza.


Many viruses affecting equines are also important human pathogens. Diseases like Eastern equine encephalitis (EEE), Western equine encephalitis (WEE), and Venezuelan-equine encephalitis (VEE) are highly infectious and can be disseminated as aerosols. A large number of horses and human cases of VEE with fatal encephalitis have continuously occurred in Venezuela and Colombia. Vesicular stomatitis (VS) is prevalent in horses in North America and has zoonotic potential causing encephalitis in children. Hendra virus (HeV) causes respiratory and neurological disease and death in man and horses. Since its first outbreak in 1994, 53 disease incidents have been reported in Australia. West Nile fever has spread to many newer territories across continents during recent years.

It has been described in Africa, Europe, South Asia, Oceania and North America. Japanese encephalitis has expanded horizons from Asia to western Pacific region including the eastern Indonesian archipelago, Papua New Guinea and Australia. Rabies is rare in horses but still a public health concern being a fatal disease. Equine influenza is historically not known to affect humans but many scientists have mixed opinions. Equine viral diseases of zoonotic importance and their impact on animal and human health have been elaborated in this article.


Equine viral diseases though restricted to certain geographical areas have huge impact on equine and human health. Diseases like West Nile fever, Hendra, VS, VEE, EEE, JE, Rabies have the potential for spread and ability to cause disease in human. Equine influenza is historically not known to affect humans but some experimental and observational evidence show that H3N8 influenza virus has infected man. Despite our pursuit of understanding the complexity of the vector-host-pathogen mediating disease transmission, it is not possible to make generalized predictions concerning the degree of impact of disease emergence. A targeted, multidisciplinary effort is required to understand the risk factors for zoonosis and apply the interventions necessary to control it.

Keywords: Zoonotic diseases, Equine viral diseases, Human health, Animal health, Viral diseases, Pandemics.


Zoonotic diseases are the infectious diseases that can be transmitted to human beings from animals and vice versa either directly through contact or indirectly through contaminated inanimate objects, intermediate hosts and bites of insect vectors etc [1]. Out of the 1407 pathogens affecting human beings, 816 (58%) are of animal origin and approximately 73% of emerging human pathogens are zoonotic in nature [2].The pathogens continue to spread due to increased and faster movement of animals to newer locations, expanding international trade, increasing urbanization, environmental changes, increasing numbers of immune-compromised patients and many more associated factors [3]. Zoonotic viral diseases like Ebola, Middle East Respiratory Syndrome, West Nile, SARS-Corona, Nipah, Hendra, Avian influenza and Swine influenza are the examples of diseases which have threatened health and economies around the world. Japanese encephalitis virus (JEV) has spread throughout Asia and Australia and has also been reported in non-endemic countries like the United States in travel-associated cases [4, 5]. Increased movement of equines for trade, sports, breeding or other purposes has also enhanced the possibility of the spread of equine diseases to newer territories. Many equine viral diseases like Eastern equine encephalitis (EEE), Western equine encephalitis (WEE), and Venezuelan-equine encephalitis (VEE) can be also be disseminated through aerosols and are highly infectious [6-8]. Vesicular stomatitis (VS) is prevalent in many countries of the world and has zoonotic potential [9]. Infectious disease caused by Hendra virus has shown its impact by the death of horses and people in Australia [10].West Nile fever has spread to many new territories during recent years [11]. Rabies is relatively rare in equines but still a public health concern [12-15]. Rabies cases have been reported in mules [16] and donkeys [17]. Middle East Respiratory Syndrome-Corona Virus (MERS-CoV) is another emerging zoonotic virus. MERS-CoV needs dipeptidyl-peptidase-4 (DPP-4) receptors on host cells for infection. Molecular studies have revealed similarity between human and equine dipeptidyl-peptidase-4 (DPP-4) receptors for viral spike proteins of MERS-CoV indicating possible susceptibility of horses to this novel virus [18-20]. Equine influenza is historically not known to affect humans but many scientists have mixed opinions. Equine influenza H3N8 viruses have been reported to infect man occasionally.

In this article, an overview of viral diseases common to equines and human beings along with a focus on their impact is presented. The information will be useful to increase awareness about these diseases and guide devising effective strategies for the prevention and control of these infections.

1.1. West Nile Viral Encephalitis

West Nile virus (WNV) is a zoonotic Flavivirus belonging to the family Flaviviridae [21]. The virus is transmitted by mosquitoes and causes fatal encephalitis in human [22-27], equines [28-30] and birds [31-34].

WNV was first isolated and identified in 1937 from a woman presented with mild febrile illness in the Nile district of Uganda [35]. It has been described in Africa, Europe, South Asia, Oceania and North America [36-38]. Countries with incidence/serological evidence are presented in Fig. (1). In North America, more than 1.8 million people have been infected, with over 12,852 reported cases of encephalitis or meningitis and 1,308 deaths from 1999 to 2010 [39]. The mortality rate in human varies from 3-15% and can reach up to 50% in clinically affected horses [40]. WNV in India has been confirmed by seroprevalence and by virus isolation on different occasions from mosquitoes [41-43] bat [44] and man [42, 45-47]. WNV infection has also been reported in animals and birds [48-52].

Fig. (1). Disease distribution map of West Nile Fever showing worldwide incidence of the disease; Countries with history of infections/serological evidence are marked red and with no history are marked green.

Horses and human are the main hosts. Animals other than horses may be susceptible to WNV, but rarely become ill. Antibodies have been found in serum samples from bats, horse, dogs, cats, racoons, opossums, squirrels, domestic rabbits, eastern striped skunks, cows, sheep, deer and pigs [53-60]. The virus is transmitted to humans by mosquitoes. About 20% of the infected people develop fever with other symptoms. Fatal, neurologic illness occurs in less than 1% of infected people [61].

WNV is amplified by continuous transmission cycles between mosquitoes and birds. Generally Culex mosquitoes are the vectors and passerine birds are the vertebrate reservoirs in enzootic transmission cycles. The virus is carried in the salivary glands of infected mosquitoes and transmitted to susceptible birds during blood-sucking. Competent bird reservoirs sustain an infectious viraemia for 1 to 4 days subsequent to exposure, and then develop life-long immunity. Horses, human and most other mammals rarely develop the infectious levels of viraemia and are dead-end hosts. Few cases in human have been spread through blood transfusions, organ transplants, breast feeding and during pregnancy [62]. The ticks observed to be infected naturally include Ornithodoros maritimus, Argas hermanni and Hyalomma marginatum and the virus has also been isolated from other species of hard ticks in Africa, Europe and Asia [36, 63, 64]. Swallow bugs (Oeciacus hirundinis) have been implicated as vectors in Austria [36]. In most of the horses bitten by carrier mosquitoes, there is no disease. Approximately 33% of the infected horses develop severe disease and die or are affected severely [65-67]. The time between the bite of an infected mosquito and appearance of clinical signs ranges from 3 to 14 days. The symptoms in horses may vary from none to trembling, skin twitching and ataxia [68]. There can be sleepiness, dullness, listlessness, facial paralysis, difficulty in urination and defecation, and inability to rise. In some horses, there can be mild fever, blindness, seizures, and other signs.

There is no effective treatment for clinical WNV infection in humans, horses or any other animal. Vaccines are available for control of WNV in horses in the USA [68-70]. Vaccination of horses protects valuable animals from a potentially fatal disease, but trade and competition practices make this undesirable as some countries use positive antibody tests and impose import restrictions. WNV encephalitis is so rare in human that vaccine development may not be feasible economically.

1.2. Hendra

Hendra virus (HeV) is a rare, emerging zoonotic virus. It causes respiratory and neurological disease and death in man and horses [71]. HeV is a member of genus Henipavirus of family Paramyxoviridae, order Mononegavirales containing two members, Hendra and Nipah viruses [21].The potential for rapid spread and ability to cause disease in man have made it a public health concern. The shift from respiratory to neurological symptoms has further raised the concerns [72]. HeV was first identified in 1994 during the first recorded outbreak of the disease in Australia [73]. Up to 2016, 53 disease incidents affecting more than 70 horses and 7 human beings have been reported mainly confined to the east coast of Australia [74].

HeV has been documented to infect horses, humans, dogs and flying foxes naturally [75-77]. Experimentally cats, pigs, hamsters, ferrets, African green monkeys and guinea pigs have been documented to exhibit symptoms when experimentally infected [78-83]. Mice are susceptible to HeV infection when exposed via the intranasal route, but resist infection when challenged by a parenteral route [84]. African fruit bats of the genus Eidolon, family Pteropodidae, have been found serologically positive for HeV antibodies indicating it’s prevalence in Africa [72]. The HeV can be transmitted through body fluids, tissues or excretions of HeV infected horses. No human-to-human transmission has been reported till date [85]. Fruit bats of the family Pteropodidae, particularly the species belonging to the Pteropus are the natural hosts for HeV. There are no visible disease symptoms in fruit bats. The transmission route is likely through contamination of pasture or feed by infected uterine fluids or fetal tissues from bats [86, 87]. Horses can be infected after the exposure to HeV present in the urine of infected bats. No evidence of transmission to humans from bats has been reported [77]. Human infections range from mild influenza-like illness to fatal respiratory or neurological disease. Infected people develop fever, headaches, myalgia, sore throat and a dry cough [88]. The viral genetic material has been recovered from nasal swabs from horses even after 2 days of experimental infection with an increase in viral loads after replication in upper respiratory tract or nasopharynx followed by viremia during clinical manifestations. This suggests the risk of transmission to human beings during preclinical stages in horse [79].

Infections in horses range from asymptomatic infection to fatal respiratory and neurological syndromes. For fatal cases, the course of illness takes an average of two days. Symptoms of infection in horses are not distinctly different from other respiratory and neurological illnesses of horses. The outbreaks in horses occur one to two weeks before illness in humans which could trigger prevention measures to prevent associated outbreaks in humans. The incubation period in horses varies between 4 and 16 days. The mortality rate in horses is about 75% [71].

There are currently no drugs available to treat HeV infection. Symptomatic treatment with supportive care is the main approach to managing the infection in people. HeV vaccine for horses, EquivacHeV (Zoetis, Parkville, VIC., Australia) has been developed [71]. The vaccine proved very effective at preventing HeV infection in experiments. The vaccine effectively checks the transmission of the disease from flying foxes to horses.

1.3. Vesicular Stomatitis

Vesicular stomatitis is a viral disease which primarily affects cattle, horses, and swine. It occurs in enzootic and epizootic forms in the tropical and subtropical areas [89]. The disease is rarely life-threatening but can have a significant financial impact on the horse industry. Vesicular stomatitis virus (VSV) is the prototype of the genus Vesiculovirus in family Rhabdoviridae [21]. The virus has two serologically distinct serotypes, VSV-New Jersey (NJ) and VSV-Indiana (IND). The neutralizing antibodies generated by these two serotypes are not cross-reactive. The IND serogroup has three subtypes IND-1 (classical IND) IND-2 (cocal virus) and IND-3 (alagoas virus) The virus is endemic in South America, Central America, Southern Mexico, Venezuela, Colombia, Ecuador and Peru but the disease has been reported in South Africa in 1886 and 1897 and France in years 1915 and 1917 [90].

The disease has been reported across continents in Belize, Bolivia, Brazil, Colombia, Costa Rica, Ecuador, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Pakistan, Panama, Peru, USA and Venezuela [91, 92]. Outbreaks historically occurred in all regions of the USA but have been limited to western states in 1995, 1997, 1998, 2004, 2005, 2006, 2009, 2010, and 2012 [93, 94]. While VS has been reported in horses at about 800 premises in eight states [95]. VSV spread to Europe during the First World War and periodically appears in South Africa. The Chandipura virus, a Vesiculovirus caused encephalitis outbreaks in different states of India leading to mortalities in children [96]. Isfahan another virus in this genus is endemic in Iran [89, 97]. The countries with incidence/serological evidence of vesicular stomatitis are presented in Fig. (2).

Fig. (2). Disease distribution map of Vesicular Stomatitis showing worldwide incidence of the disease; Countries with history of infections/serological evidence are marked red.

Clinical disease has been observed in cattle, horses, pigs and camels whereas sheep, goats and llamas tend to be resistant. White-tailed deer and numerous species of small mammals in the tropics are considered as wild hosts. Many species, including cervids, nonhuman primates, rodents, birds, dogs, antelope, and bats have shown serological evidence of infection [98-100]. Experimentally different animals like mice, rats, guinea-pig, deer, raccoons, bobcats, and monkeys can be infected.

The virus is zoonotic and causes flu-like symptoms characterized by fever, chills, nausea, vomiting, headache, retrobulbar pain, myalgia, sub-sternal pain, malaise, pharyngitis, conjunctivitis, and lymphadenitis in humans. Vesicular lesions may be present in the pharynx, buccal mucosa, or tongue [101-106]. Encephalitis is rare but may occur in children [107, 108].

The transmission is more likely by trans-cutaneous or transmucosal route. The virus can be transmitted through direct contact with infected animals having lesions of the disease or by blood-feeding insects. In endemic areas, Lutzomyia sp. (sand fly) is proven biologic vectors. Black flies (Simulidae) are the most likely biologic insect vector in USA. Other insects may also act as mechanical vectors. Saliva, exudates and epithelium from open vesicles are sources of virus. Plants and soil are also suspected as the source of virus.

Horses of all ages appear equally susceptible [109] but lesions do not appear in all susceptible horses [110]. The lesions of the disease resemble foot-and-mouth disease in cattle and the other viral vesicular diseases in pigs. The horses are resistant to foot and mouth disease and susceptible to VS. VSV is the only viral vesicular disease of livestock that infects horses [111]. VSV is also the most important of these four viruses as a zoonotic agent for humans. When vesicular stomatitis occurs in horses, blanched raised or broken vesicles or blister-like lesions develop on the tongue, mouth lining, nose and lips [112]. In some cases, lesions also develop on the udder or sheath or the coronary bands of horses. Animals may become anorectic, lethargic and have pyrexia. One of the most obvious clinical signs is drooling of saliva or frothing at the mouth. The rupture of the blisters creates painful ulcers in the mouth. The surface of the tongue may slough. Excessive salivation is often mistaken as a dental problem or colic [113]. There may be weight loss due to mouth ulcers as animal finds it too painful to eat. The lesions around the coronary band may cause lameness and laminitis. In severe cases, the lesions on the coronary band may cause the hoof to slough. Animals usually recover completely within two weeks. Morbidity rates vary between 5 and 70% but mortality is rare. Vesicular stomatitis like disease disabled 4000 horses during the Civil War in 1862. Major epidemics in the US occurred in 1889, 1906, 1916, 1926, 1937, 1949, 1963, 1982, and 1995, with minor outbreaks during many other years [114]. No specific treatment is available for the disease. Anti-inflammatory medications as supportive care help to minimize swelling and pain. Dressing the lesions with mild antiseptics may help avoid secondary bacterial infections. If fever, swelling, inflammation or pus develops around the sores, treatment with antibiotics may be required. The animals should be quarantined at least for 21 days after recovery of the last case before moving to other places. Vaccines for livestock are available in some Latin American countries.

1.4. Eastern Equine Encephalitis

Eastern equine encephalitis (EEE) commonly called triple E or, sleeping sickness is a rare but serious viral disease affecting horses and man. The disease is transmitted through mosquitoes and man and horses are dead-end hosts [115].

EEEV belongs to the genus Alphavirus of the family Togaviridae. It is closely related to Venezuelan equine encephalitis (VEE) virus and Western equine encephalitis (WEE) virus [116]. This virus has North American and South American variants. The North American variant is more pathogenic. EEE is capable of infecting a wide range of animals including mammals, birds, reptiles and amphibians [117]. The virus has been reported to cause disease in poultry, game birds and ratites. The disease has also been reported to occur in cattle, sheep, pigs, deer, and dogs though sporadically. The disease is present in North, Central and South America and the Caribbean. EEE was first recognized in the USA in 1831 from an outbreak where 75 horses died of encephalitic illness and EEE virus (EEEV) was first isolated from infection horse brain in 1933 [118]. The serological evidence and outbreaks of the disease have also been reported from horses in Canada and Brazil [119, 120]. Countries with incidence/serological evidence are presented in Fig. (3). EEEV infection in horses is often fatal. The human cases were identified first time in 1938 in the north-eastern United States. Thirty children died of encephalitis in this outbreak. The fatality rate in humans was 35%. The outbreaks of the disease also occurred in horses simultaneously in the same regions. A total of 19 human cases of the disease were reported in children between 1970-2010 in Massachusetts and New Hampshire [121]. As per the CDC reports 220 confirmed human cases of the disease occurred in the U.S. from 1964 to 2004 [122]. In 2007, a citizen of Livingston, West Lothian, Scotland became the first European victim of this disease after infected with EEEV from New Hampshire. EEE has been diagnosed in Canada, the United States of America (USA), the Caribbean Islands and Mexico [122, 123]. Eighteen cases of Eastern equine encephalomyelitis occurred in six Brazilian states between 2005 and 2009 [120].

Fig. (3). Disease distribution map of Eastern Equine Encephalitis showing incidence of the disease; Countries with history of infections/serological evidence are marked red.

Alternate infection of birds and mosquitoes maintains these viruses in nature. Culiseta melanura and Cs. morsitans species are primarily involved. Transmission of EEEV to mammals occurs via other mosquitoes which are primarily mammalian feeders and called as bridge vectors [124]. Infected mammals do not circulate enough viruses in their blood to infect additional mosquitoes. The virus is introduced by mosquitoes, but feather picking and cannibalism also contribute towards the transmission of the disease within the flocks [125]. Most people bitten by an infected mosquito do not develop any symptoms. The symptoms generally appear 3 to 10 days after the bite of an infected mosquito. The clinically affected patients may have pyrexia, muscle pains, headache, photophobia, and seizures. EEEV is one of the potential biological weapons. The disease in horses is characterized by fever, anorexia, and severe depression. Symptoms appear one to three weeks post-infection, and begin with a fever that may be as high as 106ºF. The fever usually lasts for 24–48 hours. In severe cases, the disease in horses progresses to hyper-excitability, blindness, ataxia, severe mental depression, recumbency, convulsions, and death [126]. The nervous symptoms may appear due to brain lesions. This may be followed by paralysis, causing the horse to have difficulty raising its head. The horses usually suffer complete paralysis and die two to four days after symptoms appear. Mortality rates among horses range from 70 to 90% [127].

There is no cure for EEE. Severe illnesses are treated by supportive therapy consisting of corticosteroids, anticonvulsants, intravenous fluids, tracheal intubation, and antipyretics. Vaccines containing killed virus are used for prevention of the disease. These vaccinations are usually given as combination vaccines, most commonly with WEE, VEE, and tetanus. Elimination of mosquito breeding sites and use of insect repellents may help in control of the disease.

1.5. Venezuelan Equine Encephalitis

Venezuelan equine encephalitis (VEE) is an arbovirus infection transmitted by mosquitoes. VEE viruses (VEEV) are classified in the genus Alphavirus, family Togaviridae. The VEE virus complex is composed of six subtypes (I–VI); Subtype I includes five antigenic variants (AB–F), of which variants 1-AB and 1-C are associated with epizootics in equines and concurrent epidemics in humans [128]. The epizootic variants 1-AB and 1-C are thought to originate from mutations of the enzootic 1-D serotype [129]. The enzootic strains are 1-D, 1-E and 1-F of subtype I, subtype II, four antigenic variants (A–D) of subtype III, and subtypes IV–VI. The enzootic viruses do not produce clinical encephalomyelitis in the equines normally. Enzootic VEE strains have been identified as Everglades (subtype II) in the Florida, variant I-E in Central American countries and Mexico, variants I-D and I-E in Panama, variant I-D in Venezuela, Colombia, variants 1-D, III-C, and III-D in Peru, variant III-B and subtype V in French Guiana, variant I-D in Ecuador, variant III-A in Suriname and Trinidad, variants I-F and III-A and subtype IV in Brazil and subtype VI in Argentina. In an atypical ecological niche, variant III-B has been isolated in the USA (Colorado and South Dakota) in an unusual association with birds [128]. Countries with incidence/serological evidence are presented in Fig. (4).

Fig. (4). Disease distribution map of Venezuelan Equine Encephalitis showing incidence of the disease; Countries with history of infections/serological evidence are marked red.

The primary vectors for the bird or rodent-mosquito life cycle are members of the Melanoconion subgenus (Culex cedecci). Epizootic VEEV strains (I-AB and I- C) are transmitted by several mosquito vectors (e.g., Aedes and Psorophora spp.) to equids [130].

Infections with VEE virus (VEEV) may present, in both humans and horses, as either encephalitic disease or as simply a febrile disease without profound neurologic signs. Horses may die after a very acute course, even without any neurologic signs, but mortality in humans is generally low. Horses are not dead-end hosts for VEEV epizootic strains like they are for EEEV and WEEV. Horses are, in fact, the key reservoir species for the epizootic strains of VEEV that cause clinical disease in both horses and humans [128].

Epizootic subtypes highly pathogenic to equines, can spread rapidly through large populations. Equines are the primary animal species and serve as amplifying hosts for epizootic VEE virus strains. Blood-sucking insects feed on infected horses, pick up this virus and transmit to other animals or humans. Animal like cattle, swine, and dogs, can become infected, but they neither show the signs of the disease nor contribute to spread [131]. Aerosol transmission has been reported in human from laboratory accidents [128, 132]. Infections with both epizootic and enzootic variants are infectious to human beings and can occur in laboratory workers. The workers handling infectious VEE viruses or their antigens should take preventive measures including use of containment facilities and vaccination.

VEE can cause disease in equines including horses, mules, donkeys and zebras. Cattle, swine, chickens and dogs have been shown to seroconvert after epizootics; mortality has been observed in domesticated rabbits, dogs, goats and sheep. Humans also can contract this disease. Epidemics of VEE involving tens of thousands of humans have been reported. The mortality rates in equines during epizootics have been 19-83% while 4-14% in human beings associated with neurological disease [129]

It usually causes influenza like symptoms in adults, but in children and horses it can cause severe encephalitis. Equines may suddenly die or exhibit progressive central nervous system disorders. Infections with VEEV may present, in both humans and horses, as either encephalitic disease or as simply a febrile disease without profound neurologic signs. Horses may die after a very acute course, even without any neurologic signs, but mortality in humans is generally low. Young and immune compromised horses are most likely to develop clinical signs [131]. It causes only low morbidity and mortality in man but high morbidity and mortality in animals.

The epizootic VEE was initially limited to northern and western South America in Venezuela, Colombia, Ecuador, Peru and Trinidad, but the epizootics have been reported in years from 1969 to 1972 in Guatemala, Nicaragua, El Salvador, Honduras, Costa Rica, Belize, Mexico, and the United States of America due to variant 1-AB. Epizootics caused by I-AB or I-C virus have not occurred in North America and Mexico after 1972. Equine and human epizootic VEE viruses were subtype 1-C from Venezuela in 1993, 1995 and 1996 and Colombia in 1995 [128]. In 1960 over 200,000 human cases and more than 100,000 equine deaths were estimated in Central Colombia [133]. Countless cases in horses and 75,000-100,000 human cases with more than 300 fatal encephalitis cases occurred in Venezuela and Colombia in 1995 [134]. Equine disease associated with VEEV-IE occurred in Mexico and human cases of VEEV ID-associated disease occurred in Peru from 1993 to 95 [129]. Subtype II has been isolated from humans and mosquitoes from Florida; subtype III has been isolated from the Rocky Mountains and northern plains states. Sylvatic VEE viruses are endemic in North, Central, and South America in swampy environments with persistent fresh or brackish water. Epizootics have been associated with a mutation to a subtype I (A, B, C, and possibly E), a change in mammalian pathogenesis, and change to several bridge vectors.

Treatment of viral encephalitis is supportive, as there are no specific antiviral therapies. The two VEE vaccines, a modified-live vaccine (TC-83) and an inactivated adjuvant vaccine, have been used in field. Horses were vaccinated with TC-83 vaccine during outbreak in Mexico and Texas in 1971 as equine vaccine was not available but it is still in use for humans working with VEE. Formalin-inactivated virulent VEE virus vaccines are not recommended for use in equids due to risk of residual virulence [128].

1.6. Western Equine Encephalitis

Western equine encephalitis (WEE) is an uncommon viral illness of horses and human. WEE virus (WEEV) is an Alphavirus of the family Togaviridae which is maintained between birds and mosquitoes, occasionally causing disease in humans and equids [135, 136]. This is an arbovirus transmitted by mosquitoes of the genera Culex and Culiseta. It is a recombinant between Sindbis and Eastern equine encephalitis like viruses [137-139]. It has also been reported to cause disease in poultry, game birds and ratites [115]. WEEV is normally maintained between Culex tarsalis mosquitoes and birds. WEE has several subtypes consisting Sindbis, Aura, Ft. Morgan and Y 62–33. WEEV previously isolated in the south and eastern USA has been shown to belong to the HJ virus serogroup.

Horses and humans are often referred to as “dead-end” hosts as the virus does not build to high enough levels in blood to infect other mosquitoes [122]. Most people infected with WEE virus will have either no symptoms or a very mild illness. A small percentage of people, especially infants and elderly people to a lesser extent, may develop encephalitis. Approximately 5-15% of these encephalitis cases are fatal, and about 50% of surviving infants will have permanent brain damage [139].

Geographically, WEEV exists throughout uine deaths were estimated in central America and northern portions of South America, Mexico and Canada. In the US, WEEV exist in the western two third of the country. Outbreaks of the disease have been recorded since 1847. In 1930 about 6000 horses and mules were infected leading to about 50% mortalities in California. The largest epidemic was recorded in 1937 and 1938 in USA and Canada. In 1938 outbreak an estimated 264000 equids were infected with a morbidity of 21.4% [140]. In the USA, WEE is seen primarily in provinces west of the Mississippi River. During 1941, there was an outbreak of WEE in several states of US and Canada causing 300,000 cases of encephalitis in mules and horses and 3336 cases in humans [141]. The 1970s saw 209 human cases; 87 were reported during the 1980s, only 4 cases during the 1990s, and no cases have been reported in the USA or Canada since 1998 [142]. The last documented human case in North America occurred in 1994, and the virus has not been detected in mosquito pools since 2008 [143]. In human, WEEV infections tend to be asymptomatic or cause mild disease after a short incubation period of 2–7 days with nonspecific symptoms, e.g., sudden onset of fever, headache, nausea, vomiting, anorexia and malaise [139]. In some cases, additional symptoms of altered mental status, weakness and signs of meningeal irritation may be observed. In a minority of infected individuals, encephalitis or encephalomyelitis occurs and may lead to neck stiffness, confusion, tonic-clonic seizures, somnolence, coma and death. WEEV is considered as agent that the US researched as potential biological weapons before the nation suspended its biological weapons program.

In horses, infections with WEEV begin with fever, inappetence and lethargy, progressing to various degrees of excitability and then drowsiness, ultimately leading to paresis, seizures and coma in 5-10 day course of the disease [144]. The WEEV mortality rate in horses is higher than humans. Mortality of horses showing clinical signs of WEE is 20–50%. These symptomatic horses either progress to recumbency or die from WEE infections.

There is no treatment for WEE other than supportive care. Formalin-inactivated whole viral vaccines for EEE, WEE, and VEE are commercially available in mono-, bi-, or trivalent form. Previously non vaccinated adult horses require booster. For adult horses in temperate climates, an annual vaccine within 4 wk of the start of the arbovirus season is recommended. However, for horses that travel between areas affected by the virus, 2 or even 3 times vaccination in a year is recommended. Mares should be vaccinated 3–4 wk before foaling to induce colostral antibody.

1.7. Japanese Encephalitis

Japanese encephalitis (JE) is caused by JE virus belonging to genus Flavivirus of the family Flaviviridae [21]. There is only one serotype of JEV, but at least five genotypes based on phylogenetic analysis of envelop (E) gene sequences [145]. The virus is widespread in eastern, south-eastern and southern Asian countries and has spread to the western Pacific region including the eastern Indonesian archipelago, Papua New Guinea and Northern Australia and Pakistan [146, 147]. It is most common in areas under paddy cultivation with pig rearing in Vietnam [148, 149]. JE virus circulates throughout the year in tropical areas of Asia amongst birds, swine and mosquitoes. Approximately, 3 billion people live in JEV-endemic countries in Asia where 68,000 cases are reported annually [148, 150, 151]. Horses are the primarily affected domestic animals. The disease also affects humans and is a primary public health concern in Asia. The birds of the family Ardeidae (herons and egrets) are natural maintenance reservoir and generate high viraemias upon infection without clinical disease. The disease is transmitted principally by Culex spp. (Culex tritaeniorhynchus) as it has a wide host range including birds, horses, swine and humans. Pigs act as important amplifiers of the virus producing high viraemias [152, 153]. Other sub-clinically infected animals include cattle, sheep, goats, dogs, cats, chickens, ducks, wild mammals, reptiles and amphibians but generally not contribute to spread of the disease. Horses and humans are the dead-end hosts, in which JEV causes acute encephalitis [154].

Sporadic clinical cases of JE in horses have been reported in various countries including Japan [155], Hong Kong [156], Taiwan [157], and India [158]. In addition, JE sero-positivity among equines has been reported in Nepal, Korea, Indonesia, and India [158-167]. Countries with incidence/serological evidence are presented in Fig. (5). In horses three syndromic manifestations have been described. Transitory type syndrome, lethargic type syndrome and hyper-excitability type syndrome [168]. The symptoms may vary from moderate to high fever (41°C or higher) accompanied by profuse sweating and muscle tremors, aimless wandering, behavioural changes manifested by aggression, loss of vision, collapse, coma and death and neurologic sequelae may result. Morbidity rates reported from field cases vary from less than 1 to 1.4%. Mortality rate in outbreaks can vary from 5 to 15% but can reach 30–40% in more severe epizootics [168].

Fig. (5). Disease distribution map of Japanese Encephalitis showing incidence of the disease; Countries with history of infections/serological evidence are marked red.

In human beings, most infections are asymptomatic but can manifest as severe encephalitis, and with neurological sequelae in survivors. Japanese encephalitis tends to be a childhood disease in endemic areas but all ages can be affected in a naive population. As per the estimates 68000 clinical cases occur globally each year, with approximately 13600 to 20400 deaths [169]. The first case of Japanese encephalitis was documented in 1871 in Japan. Approximately 4,000 people died during the 1924 epidemic in Japan, and nearly 2500 deaths occurred in South Korea in 1949. More than 3700 equids died during an epidemic in Japan in 1949 [170]. JE was detected in India, in 1955 and was confined to Tamil Nadu. Japanese encephalitis has emerged as a major problem and several outbreaks of Japanese encephalitis are reported from different parts of the country every year. The virus has invaded 21 rice-growing states of India [171, 172]. Deaths have been reported continuously from many states of India ranging from 466 in 2002 to 680 in 1999. Till 2007, 103,389 cases have been reported in India, with 33,729 deaths [173]. There had been 116 deaths in Malkangiri district of Orissa in India in 2016. There is no treatment for Japanese encephalitis. Vaccines are available for horses, swine and humans for prophylaxis. Vaccination has reduced the number of clinical cases among horses in endemic areas.

1.8. Rabies

Rabies is caused by the rabies virus, a neurotropic virus in the genus Lyssavirus, family Rhabdoviridae. The disease is important being zoonotic and highly fatal. All mammals are susceptible, but some species like dogs, jackals, coyotes, wolves, foxes, skunks, mongooses, and raccoons and bats act as reservoir hosts. Rabies cases have been reported across the globe in more than 150 countries. The worldwide cases of human rabies are estimated to be 55,000 or more every year with annual human mortalities of about 31,000 and 24,000 in Asia and Africa, respectively [174, 175]. A Rabies virus is most commonly transmitted through contact of saliva with damaged skin or mucous membranes, so strict barrier precautions should be used in all suspected cases.

Rabies is relatively rare in horses and usually less than 100 cases are reported in the United States every year [176, 177]. A large number of rabies cases have been reported in donkeys in Sudan over a period of ten years from 1992-2002 [17]. The clinical signs in horses are variable. The paralytic and dumb forms are most common, whereas the furious form is not as common as in other species. Clinical signs in the initial stages include ataxia and paresis of the hindquarters, lameness, recumbency, pharyngeal paralysis, and colic. The major clinical signs observed over the period include recumbency, hyperesthesia, loss of tail and anal sphincter tone, fever, ataxia and paresis of the hindquarters [178]. Affected animals usually die of cardio-respiratory failure within 2 to 5 days of onset of clinical signs; however, progression can be slower (up to 2 wk) in some cases. The incubation period for rabies is typically 1–3 months but may vary from 1 week to 1 year. The clinical signs in man may include malaise, fever or headache, as well as discomfort, pain, pruritis or other sensory alterations at the site of virus entry in early stages. Either furious form with hyper-excitability or a paralytic form characterized by generalized paralysis may predominate. Death usually occurs within 2 to 10 days. Survival is rare in clinically affected patients. Severe neurological disorders may occur as sequel to the disease in survivors.

Exposure to rabies is less common in people handling equines compared to small animals or wildlife. Vaccines are available for prevention of the disease in horses but there has been documented evidence of illness even in vaccinated horses [178]. For prevention pre-exposure vaccination is recommended for people in frequent contact with animals as they are more likely to be exposed to rabies.

1.9. Equine Influenza

Equine influenza is historically not known to affect humans but many scientists have mixed opinions. Xie and co-workers [179] have reviewed English, Chinese, and Mongolian scientific literature regarding evidence for equine influenza virus infections in man. On the basis of 16 publications, the authors could find considerable experimental and observational evidence that H3N8 equine influenza viruses have occasionally infected man. Morens and Taubenberger [180] found that from 1658 to the early 20th century, EIV outbreaks in horses often preceded 3 weeks or so human influenza-like-illnesses. The likely cause of human pandemic in 1889 has also been considered to be a H3N8 EIV [181-183]. Serological studies of the people who lived from 1892 era, have also demonstrated elevated antibodies against H3N8 EIV [184, 185]. Marois and colleagues [186] reported that viral culture and serological evidence to show that the virus came from humans and also speculated EIV outbreaks in horses may pose risk to humans.


Equine viral diseases though restricted to certain geographical areas have huge impact on equine and human health. Many of these diseases have complex life cycles and require vectors for spread, while others can be contracted directly through aerosols. In some cases silent carriers like bats, pigs and passerine birds can contribute towards amplification of organisms and their spread to newer territories. A number of zoonotic diseases like West Nile fever, Hendra, VS, VEE, EEE, JE, Rabies have the potential for spread and ability to cause disease in human. Equine influenza is historically not known to affect humans but some scientists could find considerable experimental and observational evidence where H3N8 influenza virus has infected man. Despite our pursuit of understanding the complexity of the vector-host-pathogen mediating disease transmission, it is not possible to make generalized predictions concerning the degree of impact of disease emergence. The complex character and non-straightway behaviour of the human-natural systems in which host-pathogen systems are nested make specific prevalence of disease emergence or epidemics inherently difficult to predict. A targeted, multidisciplinary effort is required to understand the risk factors for zoonosis and apply the interventions necessary to control it.


Not applicable.


The author declares no conflict of interest, financial or otherwise.


Declared none


[1] Bres P. Public health action in emergencies caused by epidemics 1986; 143-57.
[2] Woolhouse MEJ, Gowtage-Sequeria S. Host range and emerging and reemerging pathogens. Emerg Infect Dis 2005; 11(12): 1842-7.
[3] Bender JB, Tsukayama DT. Horses and the risk of zoonotic infections. Vet Clin North Am Equine Pract 2004; 20(3): 643-53.
[4] Weaver SC, Reisen WK. Present and future arboviral threats. Antiviral Res 2010; 85(2): 328-45.
[5] Hills SL, Griggs AC, Fischer M. Japanese encephalitis in travelers from non-endemic countries, 1973-2008. Am J Trop Med Hyg 2010; 82(5): 930-6.
[6] Pike RM. Laboratory-associated infections: Summary and analysis of 3921 cases. Health Lab Sci 1976; 13(2): 105-14.
[7] Bellamy RJ, Freedman AR. Bioterrorism. QJM 2001; 94(4): 227-34.
[8] Roy CJ, Reed DS, Wilhelmsen CL, Hartings J, Norris S, Steele KE. Pathogenesis of aerosolized Eastern Equine Encephalitis virus infection in guinea pigs. Virol J 2009; 6: 170.
[9] Reif JS, Webb PA, Monath TP, et al. Epizootic vesicular stomatitis in Colorado, 1982: Infection in occupational risk groups. Am J Trop Med Hyg 1987; 36(1): 177-82.
[10] Epstein JH, Baker ML, Zambrana-Torrelio C, et al. Duration of Maternal Antibodies against Canine Distemper Virus and Hendra Virus in Pteropid Bats. PLoS One 2013; 8(6): e67584.
[11] Chancey C, Grinev A, Volkova E, Rios M. The global ecology and epidemiology of West Nile virus. BioMed Res Int 2015; 2015: 376230.
[12] Green SL, Smith LL, Vernau W, Beacock SM. Rabies in horses: 21 cases (1970-1990). J Am Vet Med Assoc 1992; 200(8): 1133-7.
[13] Hamir AN, Moser G, Rupprecht CE. A five year (1985-1989) retrospective study of equine neurological diseases with special reference to rabies. J Comp Pathol 1992; 106(4): 411-21.
[14] Krebs JW, Mondul AM, Rupprecht CE, Childs JE. Rabies surveillance in the United States during 2000. J Am Vet Med Assoc 2001; 219(12): 1687-99.
[15] Krebs JW, Wheeling JT, Childs JE. Rabies surveillance in the United States during 2002. J Am Vet Med Assoc 2003; 223(12): 1736-48.
[16] Numan M, Qureshi ZA, Shauket M, et al. Rabies out-break in mules at Mansehra, Pakistan. Res Vet Sci 2011; 90(1): 160-2.
[17] Ali Y, Intisar S, Wegdan H, Ali E. Epidemiology of Rabies in Sudan. J Anim Vet Adv 2006; 5(3): 266-70.
[18] Mohd HA, Al-Tawfiq JA, Memish ZA. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) origin and animal reservoir. Virol J 2016; 13: 87.
[19] Bosch BJ, Raj VS, Haagmans BL. Spiking the MERS-coronavirus receptor. Cell Res 2013; 23(9): 1069-70.
[20] Barlan A, Zhao J, Sarkar MK, et al. Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection. J Virol 2014; 88(9): 4953-61.
[21] Lefkowittz EJ. 2017. ICTV/MSL. International Committee on Taonomy of Viruses/ Master Species List (Version Oct 2015) In Ruskov Y, Abucay L, Orell T, Nicolson D, Bailly N, Kirk PM, Bourgoin T, DeWalt RE, Decock W, De WeverA, Nieukerken EV, Zarucchi J, Penel L 9Eds) (2017) Species 2000 and IT IS Catalogue of Life, 30th June 2017 Digital resource at WWW.
[22] Centers for Disease Control and Prevention (CDC). - Update - West Nile virus encephalitis - New York, 1999. Morb Mortal Wkly Rep 1999; 48(41): 944-6.
[23] Le Guenno B, Bougermouh A, Azzam T, Bouakaz R. West Nile: A deadly virus? Lancet 1996; 348(9037): 1315.
[24] Piţigoi D, Popa MI, Streinu-Cercel A. The epidemiological process of West Nile viral infection. Bacteriol Virusol Parazitol Epidemiol 1998; 43(4): 281-8. [in Romanian].
[25] Tsai TF, Popovici F, Cernescu C, Campbell GL, Nedelcu NI. West Nile encephalitis epidemic in southeastern Romania. Lancet 1998; 352(9130): 767-71.
[26] Hubálek Z, Halouzka J, Juricová Z, Príkazský Z, Záková J, Sebesta O. Surveillance of mosquito-borne viruses in Breclav after the flood of 1997. Epidemiol Mikrobiol Imunol 1999; 48(3): 91-6. [in Czech].
[27] Nur YA, Groen J, Heuvelmans H, Tuynman W, Copra C, Osterhaus ADME. An outbreak of West Nile fever among migrants in Kisangani, Democratic Republic of Congo. Am J Trop Med Hyg 1999; 61(6): 885-8.
[28] Schmidt JR, Elmansoury HK. Natural and experimental infection of Egyptian equines with West Nile virus. Ann Trop Med Parasitol 1963; 57: 415-27.
[29] Tber AA. West Nile fever in horses in Morocco. Bull OIE 1996; 108(11): 867-9.
[30] Cantile C, Di Guardo G, Eleni C, Arispici M. Clinical and neuropathological features of West Nile virus equine encephalomyelitis in Italy. Equine Vet J 2000; 32(1): 31-5.
[31] Work TH, Hurlbut HS, Taylor RM. Indigenous wild birds of the Nile Delta as potential West Nile virus circulating reservoirs. Am J Trop Med Hyg 1955; 4(5): 872-88.
[32] Nir Y, Goldwasser R, Lasowski Y, Avivi A. Isolation of arboviruses from wild birds in Israel. Am J Epidemiol 1967; 86(2): 372-8.
[33] Marshall ID, Brown BK, Keith K, Gard GP, Thibos E. Variation in arbovirus infection rates in species of birds sampled in a serological survey during an encephalitis epidemic in the Murray Valley of South-eastern Australia, February 1974. Aust J Exp Biol Med Sci 1982; 60(Pt 5): 471-8.
[34] Steele KE, Linn MJ, Schoepp RJ, et al. Pathology of fatal West Nile virus infections in native and exotic birds during the 1999 outbreak in New York City, New York. Vet Pathol 2000; 37(3): 208-24.
[35] Smithburn KC, Hughes TP, Burke AW, Paul JH. A neurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med 1940; 20: 471-92.
[36] Komar N. West Nile viral encephalitis. Rev Sci Tech Off Int. Epiz 2000; 19(1): 166-76.
[37] Pattan SR, Dighe NS, Bhawar SB, et al. West Nile Fever: An Overview. J Biomed Sci and Res 2009; 1: 33-48.
[38] Murgue B, Murri S, Triki H, Deubel V, Zeller HG. West Nile in the Mediterranean basin: 1950-2000. Ann N Y Acad Sci 2001; 951: 117-26.
[39] Kilpatrick AM. Globalization, land use, and the invasion of West Nile virus. Science 2011; 334(6054): 323-7.
[40] Angenvoort J, Brault AC, Bowen RA, Groschup MH. West Nile viral infection of equids. Vet Microbiol 2013; 167(1-2): 168-80.
[41] Dandawate CN, Rajagopalan PK, Pavri KM, Work TH. Virus isolations from mosquitoes collected in North Arcot district, Madras state, and Chittoor district, Andhra Pradesh between November 1955 and October 1957. Indian J Med Res 1969; 57(8): 1420-6.
[42] Rodrigues FM, Singh BP, Dandawate CN, Soman RS, Guttikar SN, Kaul HN. Isolation of Japanese encephalitis and West Nile viruses from mosquitoes collected in Andhra Pradesh. Indian J Parasitol 1980; 4: 149-53.
[43] Pavri KM, Singh KR. Isolation of West Nile virus from Culex fatigans mosquitoes from western India. Indian J Med Res 1965; 53: 501-5.
[44] Paul SD, Rajagopalan PK, Sreenivasan MA. Isolation of the West Nile virus from the frugivorous bat, Rousettus leschenaulti. Indian J Med Res 1970; 58(9): 1169-71.
[45] Banker DD. Preliminary observations on antibody patterns against certain viruses among inhabitants of Bombay city. Indian J Med Sci 1952; 6: 733-46.
[46] Paramasivan R, Mishra AC, Mourya DT. West Nile virus: The Indian scenario. Indian J Med Res 2003; 118: 101-8.
[47] George S, Gourie-Devi M, Rao JA, Prasad SR, Pavri KM. Isolation of West Nile virus from the brains of children who had died of encephalitis. Bull World Health Organ 1984; 62(6): 879-82.
[48] Rodrigues FM, Guttikar SN, Pinto BD. Prevalence of antibodies to Japanese encephalitis and West Nile viruses among wild birds in the Krishna-Godavari Delta, Andhra Pradesh, India. Trans R Soc Trop Med Hyg 1981; 75(2): 258-62.
[49] Ratho RK, Sethi S, Prasad SR. Prevalence of Japanese encephalitis and West Nile viral infections in pig population in and around Chandigarh. J Commun Dis 1999; 31(2): 113-6.
[50] Mishra N, Kalaiyarasu S, Nagarajan S, et al. Serological evidence of West Nile virus infection in wild migratory and resident water birds in Eastern and Northern India. Comp Immunol Microbiol Infect Dis 2012; 35(6): 591-8.
[51] Balakrishnan A, Butte DK, Jadhav SM. Complete genome sequence of west nile virus isolated from alappuzha district, kerala, India. Genome Announc 2013; 1(3): 1.
[52] Chowdhury P, Khan SA, Dutta P, Topno R, Mahanta J. Characterization of West Nile virus (WNV) isolates from Assam, India: Insights into the circulating WNV in northeastern India. Comp Immunol Microbiol Infect Dis 2014; 37(1): 39-47.
[53] Bunde JM, Heske EJ, Mateus-Pinilla NE, Hofmann JE, Novak RJ. A survey for West Nile virus in bats from Illinois. J Wildl Dis 2006; 42(2): 455-8.
[54] Giadinis N, Katsoulos P, Chochlakis D, et al. Serological investigation for West Nile virus, Anaplasma ovis and Leishmania infantum in Greek cattle. Vet Ital 2015; 51(3): 205-9.
[55] Ergunay K, Gunay F, Erisoz Kasap O, Oter K, Gargari S, Karaoglu T, et al. Serological, Molecular and Entomological Surveillance Demonstrates Widespread Circulation of West Nile Virus in Turkey Charrel R, ed PLoS Neglected Tropical Diseases 2014; 8(7)
[56] Lan D, Ji W, Yu D, et al. Serological evidence of West Nile virus in dogs and cats in China. Arch Virol 2011; 156(5): 893-5.
[57] Escribano-Romero E, Lupulović D, Merino-Ramos T, et al. West Nile virus serosurveillance in pigs, wild boars, and roe deer in Serbia. Vet Microbiol 2015; 176(3-4): 365-9.
[58] Blitvich BJ, Juarez LI, Tucker BJ, Rowley WA, Platt KB. Antibodies to West Nile virus in raccoons and other wild peridomestic mammals in Iowa. J Wildl Dis 2009; 45(4): 1163-8.
[59] Bisanzio D, McMillan JR, Barreto JG, et al. Evidence for West Nile virus spillover into the squirrel population in Atlanta, Georgia. Vector Borne Zoonotic Dis 2015; 15(5): 303-10.
[60] Bentler KT, Hall JS, Root JJ, et al. Serologic evidence of West Nile virus exposure in North American mesopredators. Am J Trop Med Hyg 2007; 76(1): 173-9.
[61] WHO West Nile Virus 354: 3 screen shots 2011. Available from:>
[62] Hayes EB, O’Leary DR. West Nile virus infection: A pediatric perspective. Pediatrics 2004; 113(5): 1375-81.
[63] Lwande OW, Venter M, Lutomiah J, et al. Whole genome phylogenetic investigation of a West Nile virus strain isolated from a tick sampled from livestock in north eastern Kenya. Parasit Vectors 2014; 7: 542.
[64] Kolodziejek J, Marinov M, Kiss BJ, Alexe V, Nowotny N. The Complete Sequence of a West Nile Virus Lineage 2 Strain Detected in a Hyalomma marginatum marginatum Tick Collected from a Song Thrush (Turdusphilomelos) in Eastern Romania in 2013 Revealed Closest Genetic Relationship to Strain Volgograd 2007 Coffey LL, ed PLoS ONE 2014.
[65] Ostlund EN, Crom RL, Pedersen DD, Johnson DJ, Williams WO, Schmitt BJ. Equine West Nile encephalitis, United States. Emerg Infect Dis 2001; 7(4): 665-9.
[66] Salazar P, Traub-Dargatz JL, Morley PS, et al. Outcome of equids with clinical signs of West Nile virus infection and factors associated with death. J Am Vet Med Assoc 2004; 225(2): 267-74.
[67] Schuler LA, Khaitsa ML, Dyer NW, Stoltenow CL. Evaluation of an outbreak of West Nile virus infection in horses: 569 cases (2002). J Am Vet Med Assoc 2004; 225(7): 1084-9.
[68] Trock SC, Meade BJ, Glaser AL, et al. West Nile virus outbreak among horses in New York State, 1999 and 2000. Emerg Infect Dis 2001; 7(4): 745-7.
[69] De Filette M, Ulbert S, Diamond M, Sanders NN. Recent progress in West Nile virus diagnosis and vaccination. Vet Res (Faisalabad) 2012; 43: 16.
[70] Iyer AV, Kousoulas KG. A review of vaccine approaches for West Nile virus. Int J Environ Res Public Health 2013; 10(9): 4200-23.
[71] Middleton D. Hendra virus. Vet Clin North Am Equine Pract 2014; 30(3): 579-89.
[72] WHO. Hendra Virus 329: 3 screen shots; 2009. Available from http:// www.wired health resources/ NA/WHO-FS_HendraVirus.pdf
[73] Tulsiani SM, Graham GC, Moore PR, et al. Emerging tropical diseases in Australia. Part 5. Hendra virus. Ann Trop Med Parasitol 2011; 105(1): 1-11.
[74] WHO. Emergencies preparedness, response: Hendra Virus (HeV) Infection
[75] Halpin K, Young PL, Field HE, Mackenzie JS. Isolation of Hendra virus from pteropid bats: A natural reservoir of Hendra virus. J Gen Virol 2000; 81(Pt 8): 1927-32.
[76] Young PL, Halpin K, Selleck PW, et al. Serologic evidence for the presence in Pteropus bats of a paramyxovirus related to equine morbillivirus. Emerg Infect Dis 1996; 2(3): 239-40.
[77] Field HE. Hendra virus ecology and transmission. Curr Opin Virol 2016; 16: 120-5.
[78] Guillaume V, Wong KT, Looi RY, et al. Acute Hendra virus infection: Analysis of the pathogenesis and passive antibody protection in the hamster model. Virology 2009; 387(2): 459-65.
[79] Marsh GA, Haining J, Hancock TJ, et al. Experimental infection of horses with Hendra virus/Australia/horse/2008/Redlands. Emerg Infect Dis 2011; 17(12): 2232-8.
[80] Rockx B, Bossart KN, Feldmann F, et al. A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment. J Virol 2010; 84(19): 9831-9.
[81] Westbury HA, Hooper PT, Brouwer SL, Selleck PW. Susceptibility of cats to equine morbillivirus. Aust Vet J 1996; 74(2): 132-4.
[82] Hooper PT, Westbury HA, Russell GM. The lesions of experimental equine morbillivirus disease in cats and guinea pigs. Vet Pathol 1997; 34(4): 323-9.
[83] Li M, Embury-Hyatt C, Weingartl HM. Experimental inoculation study indicates swine as a potential host for Hendra virus. Vet Res 2010; 41(3): 33.
[84] Dups J, Middleton D, Yamada M, et al. A New Model for Hendra Virus Encephalitis in the Mouse. Tripp R, ed PLoS ONE 2012; 7(7): e40308..
[85] Middleton DJ, Westbury HA, Morrissy CJ, et al. Experimental Nipah virus infection in pigs and cats. J Comp Pathol 2002; 126(2-3): 124-36.
[86] Field H, Young P, Yob JM, Mills J, Hall L, Mackenzie J. The natural history of Hendra and Nipah viruses. Microbes Infect 2001; 3(4): 307-14.
[87] Edson D, Field H, McMichael L, et al. Routes of Hendra Virus Excretion in Naturally-Infected Flying-Foxes: Implications for Viral Transmission and Spillover Risk. PLoS One 2015; 10(10): e0140670.
[88] Chomel BB, Stuckey MJ, Boulouis H-J, Aguilar-Setién A. Bat-Related Zoonoses.Infections Affecting Humans and Animals: Focus On Public Health Aspects 2015; 697-714. Available at
[89] Afshar A, Shakarchi NH, Dulac GC. Development of a competitive enzyme-linked immunosorbent assay for detection of bovine, ovine, porcine, and equine antibodies to vesicular stomatitis virus. J Clin Microbiol 1993; 31(7): 1860-5.
[91] OIE. Vesicular Stomartitis. 2013. Available from Disease_cards/ VESICULAR_STOMATITIS.pdf
[93] Rodríguez LL. Emergence and re-emergence of vesicular stomatitis in the United States. Virus Res 2002; 85(2): 211-9.
[94] McCluskey BJ, Pelzel-McCluskey AM, Creekmore L, Schiltz J. Vesicular stomatitis outbreak in the southwestern United States, 2012. J Vet Diagn Invest 2013; 25(5): 608-13.
[95] Timoney P. Vesicular stomatitis. Vet Rec 2016; 179(5): 119-20.
[96] Cherian SS, Gunjikar RS, Banerjee A, Kumar S, Arankalle VA. Whole genomes of Chandipura virus isolates and comparative analysis with other rhabdoviruses. PLoS One 2012; 7(1): e30315.
[97] Tesh R, Saidi S, Javadian E. Loh P andNadim A. Isfahan virus, a new vesiculovirus infecting humans, gerbils, and sandflies [Phlebotomus papatasi] in Iran. Am J Trop Med Hyg 1977; 26: 299-306.
[98] Aguirre AA, McLean RG, Cook RS, Quan TJ. Serologic survey for selected arboviruses and other potential pathogens in wildlife from Mexico. J Wildl Dis 1992; 28(3): 435-42.
[99] Jiménez AE, Jiménez C, Castro L, Rodríguez L. Serological survey of small mammals in a vesicular stomatitis virus enzootic area. J Wildl Dis 1996; 32(2): 274-9.
[100] Tesh RB, Peralta PH, Johnson KM. Ecologic studies of vesicular stomatitis virus. I. Prevalence of infection among animals and humans living in an area of endemic VSV activity. Am J Epidemiol 1969; 90(3): 255-61.
[101] Hanson RP, Rasmussen AF Jr, Brandly CA, Brown JW. Human infection with the virus of vesicular stomatitis. J Lab Clin Med 1950; 36(5): 754-8.
[102] Patterson WC, Mott LO, Jenney EW. A study of vesicular stomatitis in man. J Am Vet Med Assoc 1958; 133(1): 57-62.
[103] Ellis EM, Kendall HE. The public health and economic effects of vesicular stomatitis in a herd of dairy cattle. J Am Vet Med Assoc 1964; 144: 377-80.
[104] Johnson KM, Vogel JE, Peralta PH. Clinical and serological response to laboratory-acquired human infection by Indiana type vesicular stomatitis virus (VSV). Am J Trop Med Hyg 1966; 15(2): 244-6.
[105] Fields BN, Hawkins K. Human infection with the virus of vesicular stomatitis during an epizootic. N Engl J Med 1967; 277(19): 989-94.
[106] Reif JS, Webb PA, Monath TP, et al. Epizootic vesicular stomatitis in Colorado, 1982: infection in occupational risk groups. Am J Trop Med Hyg 1987; 36(1): 177-82.
[108] Jones FM. Isolation of vesicular stomatitis virus from a child with signs of encephalitis. Proceedings of the 91st Annual Meeting 1987; 324-1.
[109] Burton AC. “Stomatitis Contagiosa” in horses. Vet J 1917; 73: 234-42.
[110] Webb PA, Monath TP, Reif JS, et al. Epizootic vesicular stomatitis in Colorado, 1982: epidemiologic studies along the northern Colorado front range. Am J Trop Med Hyg 1987; 36(1): 183-8.
[111] Liu D, Belák S. Vesicular Stomatitis Virus.Molecular Detection of Animal Viral Pathogens 2016; 369-74.
[112] Cargnelutti JF, Olinda RG, Maia LA, et al. Outbreaks of Vesicular stomatitis Alagoas virus in horses and cattle in northeastern Brazil. J Vet Diagn Invest 2014; 26(6): 788-94.
[114] Letchworth GJ, Rodriguez LL, Del cbarrera J. Vesicular stomatitis. Vet J 1999; 157(3): 239-60.
[115] World Organization of Animal Health (OIE). Equine Encephalomyelitis (Chapter 255) In: Manual of diagnostic tests and vaccines 2017. _EQUINE_ENCEPH.pdf
[116] Aréchiga-Ceballos N, Aguilar-Setién A. Alphaviral equine encephalomyelitis (Eastern, Western and Venezuelan). Rev - Off Int Epizoot 2015; 34(2): 491-501.
[117] White G, Ottendorfer C, Graham S, Unnasch TR. Competency of reptiles and amphibians for eastern equine encephalitis virus. Am J Trop Med Hyg 2011; 85(3): 421-5.
[118] Giltner LT, Shahan MS. The immunological relationship of eastern and western strains of equine encephalomyelitis virus. Science 1933; 78(2034): 587-8.
[119] Rocheleau JP, Arsenault J, Lindsay LR, et al. Eastern equine encephalitis virus: High seroprevalence in horses from Southern Quebec, Canada, 2012. Vector Borne Zoonotic Dis 2013; 13(10): 712-8.
[120] de Novaes Oliveira R, Iamamoto K, Silva ML, et al. Eastern equine encephalitis cases among horses in Brazil between 2005 and 2009. Arch Virol 2014; 159(10): 2615-20.
[121] Silverman MA, Misasi J, Smole S, et al. Eastern equine encephalitis in children, Massachusetts and New Hampshire, USA, 1970–2010. Emerg Infect Dis 2013.
[122] Zacks MA, Paessler S. Encephalitic alphaviruses. Vet Microbiol 2010; 140(3-4): 281-6.
[123] Oliver J, Lukacik G, Kramer LD, Backenson PB, Sherwood JA, Howard JJ. Geography and Timing of Cases of Eastern Equine Encephalitis in New York State from 1992 to 2012. Vector Borne Zoonotic Dis 2016; 16(4): 283-9.
[124] Cupp EW, Klingler K, Hassan HK, Viguers LM, Unnasch TR. Transmission of eastern equine encephalomyelitis virus in central Alabama. Am J Trop Med Hyg 2003; 68(4): 495-500.
[125] OIE (Office International des Epizooties) Revue scientifique et technique, Diseases of poultry; world trade and public health implications 2000; 19(2): 664.
[126] Chénier S, Côté G, Vanderstock J, Macieira S, Laperle A, Hélie P. An eastern equine encephalomyelitis (EEE) outbreak in Quebec in the fall of 2008. Can Vet J 2010; 51(9): 1011-5.
[127] Franklin RP, Kinde H, Jay MT, et al. Eastern equine encephalomyelitis virus infection in a horse from California. Emerg Infect Dis 2002; 8(3): 283-8.
[128] World Organization of Animal Health (OIE). 2017.
[129] Weaver SC, Ferro C, Barrera R, Boshell J, Navarro JC. Venezuelan equine encephalitis. Annu Rev Entomol 2004; 49: 141-74.
[130] Weaver SC, Powers AM, Brault AC, Barrett AD. Molecular epidemiological studies of veterinary arboviral encephalitides. Vet J 1999; 157(2): 123-38.
[131] Go YY, Balasuriya UBR, Lee CK. Zoonotic encephalitides caused by arboviruses: Transmission and epidemiology of alphaviruses and flaviviruses. Clin Exp Vaccine Res 2014; 3(1): 58-77.
[132] Quiroz E, Aguilar PV, Cisneros J, Tesh RB, Weaver SC. Venezuelan equine encephalitis in Panama: Fatal endemic disease and genetic diversity of etiologic viral strains. PLoS Negl Trop Dis 2009; 3(6): e472.
[133] Groot H. The health and economic impact of Venezuelan equine encephalitis 1972.
[134] Rivas F, Diaz LA, Cardenas VM, et al. Epidemic Venezuelan equine encephalitis in La Guajira, Colombia, 1995. J Infect Dis 1997; 175(4): 828-32.
[135] Hardy JL, Reeves WC, Scrivani RP, Roberts DR. Wild mammals as hosts of group A and group B arboviruses in Kern County, California. A five-year serologic and virologic survey. Am J Trop Med Hyg 1974; 23(6): 1165-77.
[136] Hardy JL, Milby MM, Wright ME, Beck AJ, Presser SB, Bruen JP. Natural and experimental arboviral infections in a population of blacktail jackrabbits along the sacramento river in butte county, california (1971-1974). J Wildl Dis 1977; 13(4): 383-92.
[137] Netolitzky DJ, Schmaltz FL, Parker MD, et al. Complete genomic RNA sequence of western equine encephalitis virus and expression of the structural genes. J Gen Virol 2000; 81(Pt 1): 151-9.
[138] Hahn CS, Lustig S, Strauss EG, Strauss JH. Western equine encephalitis virus is a recombinant virus. Proc Natl Acad Sci USA 1988; 85(16): 5997-6001.
[139] Weaver SC, Kang W, Shirako Y, Rumenapf T, Strauss EG, Strauss JH. Recombinational history and molecular evolution of western equine encephalomyelitis complex alphaviruses. J Virol 1997; 71(1): 613-23.
[140] Cameron GDW. Western equine encephalitis. Can J Public Health 1942; 33(8): 383-7.
[142] CDC. Western equine encephalitis virus neuroinvasive disease cases reported by state, 1964 –2010. Centers for Disease Control and Prevention, Atlanta, GA 2010. /epi.html
[143] Bergren NA, Auguste AJ, Forrester NL, Negi SS, Braun WA, Weaver SC. Western equine encephalitis virus: Evolutionary analysis of a declining alphavirus based on complete genome sequences. J Virol 2014; 88(16): 9260-7.
[144] CFSPH. Eastern, Western and Venezuelan Equine Encephalomyelitis 2015. Available from: easter_western_ venezuelan_equine_encephalomyelitis.pdf
[145] Uchil PD, Satchidanandam V. Phylogenetic analysis of Japanese encephalitis virus: Envelope gene based analysis reveals a fifth genotype, geographic clustering, and multiple introductions of the virus into the Indian subcontinent. Am J Trop Med Hyg 2001; 65(3): 242-51.
[146] Nga PT, del Carmen Parquet M, Cuong VD, et al. Shift in Japanese encephalitis virus (JEV) genotype circulating in northern Vietnam: implications for frequent introductions of JEV from Southeast Asia to East Asia. J Gen Virol 2004; 85(Pt 6): 1625-31.
[147] Hanna JN, Ritchie SA, Phillips DA, et al. An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995. Med J Aust 1996; 165(5): 256-60.
[148] Erlanger TE, Weiss S, Keiser J, Utzinger J, Wiedenmayer K. Past, present, and future of Japanese encephalitis. Emerg Infect Dis 2009; 15(1): 1-7.
[149] Lindahl JF, Ståhl K, Chirico J, Boqvist S, Thu HT, Magnusson U. Circulation of Japanese encephalitis virus in pigs and mosquito vectors within Can Tho city, Vietnam. PLoS Negl Trop Dis 2013; 7(4): e2153.
[150] 2014.
[151] Rajashekarmurthy, Keshavamurthy ML, Panigrahi NK, Basavaraja GV, Srinivas SK. Temporal lobe involvement: A diagnostic challenge in Japanese encephalitis. Indian J Child Health (Bhopal) 2015; 2(3): 140-1.
[152] Konno J, Endo K, Agatsuma H, Ishida N. Cyclic outbreaks of Japanese encephalitis among pigs and humans. Am J Epidemiol 1966; 84(2): 292-300.
[153] Gresser I, Hardy JL, Hu SM, Scherer WF. Factors influencing transmission of Japanese B encephalitis virus by a colonized strain of Culex tritaeniorhynchus Giles, from infected pigs and chicks to susceptible pigs and birds. Am J Trop Med Hyg 1958; 7(4): 365-73.
[154] Impoinvil DE, Baylis M, Solomon T. Japanese encephalitis: On the One Health agenda. Curr Top Microbiol Immunol 2013; 365: 205-47.
[155] Yamanaka T, Tsujimura K, Kondo T, et al. Isolation and genetic analysis of Japanese encephalitis virus from a diseased horse in Japan. J Vet Med Sci 2006; 68(3): 293-5.
[156] Lam KHK, Ellis TM, Williams DT, et al. Japanese encephalitis in a racing thoroughbred gelding in Hong Kong. Vet Rec 2005; 157(6): 168-73.
[157] Lian WC, Liau MY, Mao CL. Diagnosis and genetic analysis of Japanese encephalitis virus infected in horses. J Vet Med B Infect Dis Vet Public Health 2002; 49(8): 361-5.
[158] Raut CG, Thakare JP, Padbidri VS, et al. A focal outbreak of Japanese Encephalitis among horses in Pune district, India. J Commun Dis 2003; 35(1): 40-2.
[159] Chakravarti SK, Sardana DN, Mukherjee KK, Mitra AC, Chakrabarty MS. Serological evidence of infection with Japanese encephalitis virus in mules of eastern Himalayan region. Indian J Med Res 1981; 73: 4-7.
[160] D’Souza MB, Nagarkatti S, Rao KM. Serological evidence for arboviral infection among horses-HI test by filter paper disc method. Indian J Med Res 1978; 67(5): 708-12.
[161] Gowal D, Singh G, Gowal KN, Bhau LN, Saxena SN. Serological evidence of Japanese encephalitis virus infection in equines of North Himalayan region. Indian Vet J 1990; 67: 398-401.
[162] Mall MP, Kumar A, Malik SV. Sero-positivity of domestic animals against Japanese encephalitis in Bareilly area, U.P. J Commun Dis 1995; 27(4): 242-6.
[163] Pant GR. A serological survey of pigs, horses, and ducks in Nepal for evidence of infection with Japanese encephalitis virus. Ann N Y Acad Sci 2006; 1081: 124-9.
[164] Rai GP, Tuteja U, Kumar P. Comparison of haemagglutination inhibition and indirect fluorescent antibody tests to detect certain flavivirus antibodies in equines. Acta Microbiol Hung 1992; 39(1): 69-73.
[165] Shankar H, Mall MP, Yadav MP. Seroprevalence of group B arboviruses and equine herpes virus-1 infections in nervous disorders in equines. Indian J Anim Sci 1988; 58: 1-5.
[166] Widjaja S, Soekotjo W, Hartati S, Jennings GB, Corwin AL. Prevalence of hemagglutination-inhibition and neutralizing antibodies to arboviruses in horses of java. Southeast Asian J Trop Med Public Health 1995; 26(1): 109-13.
[167] Gulati BR, Singha H, Singh BK, Virmani N, Khurana SK, Singh RK. Serosurveillance for Japanese encephalitis virus infection among equines in India. J Vet Sci 2011; 12(4): 341-5.
[168] OIE. Technical disease cards 2017.
[169] WHO. Japanese encephalitis, Factsheet, 2015.
[170] CFSPH. Japanese Encephalitis 2016.
[171] Diagana M, Preux PM, Dumas M. Japanese encephalitis revisited. J Neurol Sci 2007; 262: 165-70.
[172] Namachivayam V, Umayal K, Eds. Proceedings of the National Conference on Japanese Encephalitis. New Delhi: Indian Council of Medical Research 1982.
[173] Dhillon GP, Raina VK. Epidemiology of Japanese encephalitis in context with Indian scenario. J Indian Med Assoc 2008; 106(10): 660-3.
[174] CFSPH. Rabies and Rabies-Related Lyssaviruses. Ames, Iowa State University, College of Veterinary Medicine. 2012; 1-10. Available from:
[175] Barecha CB, Girzaw F, Kandi RV, Pal M. Epidemiology and Public Health Significance of Rabies. Perspectives in Medical Research 2017; 5(1): 55-67.
[176] Krebs JW, Mondul AM, Rupprecht CE, Childs JE. Rabies surveillance in the United States during 2000. J Am Vet Med Assoc 2001; 219(12): 1687-99.
[177] Krebs JW, Rupprecht CE, Childs JE. Rabies surveillance in the United States during 1999. J Am Vet Med Assoc 2000; 217(12): 1799-811.
[178] Green SL, Smith LL, Vernau W, Beacock SM. Rabies in horses: 21 cases (1970-1990). J Am Vet Med Assoc 1992; 200(8): 1133-7.
[179] Xie T, Anderson BD, Daramragchaa U, Chuluunbaatar M, Gray GC. A Review of Evidence that Equine Influenza Viruses Are Zoonotic. Daly JM, ed Pathogens 2016; 5(3): 50.
[180] Morens DM, Taubenberger JK. Historical thoughts on influenza viral ecosystems, or behold a pale horse, dead dogs, failing fowl, and sick swine. Influenza Other Respir Viruses 2010; 4(6): 327-37.
[181] McAuley JL, Kedzierska K, Brown LE, Shanks GD. Host immunological factors enhancing mortality of young adults during the 1918 influenza pandemic. Front Immunol 2015; 6: 419.
[182] Wilson N, Oliver J, Rice G, et al. Age-specific mortality during the 1918-19 influenza pandemic and possible relationship to the 1889-92 influenza pandemic. J Infect Dis 2014; 210(6): 993-5.
[183] Elbadry MA, Merrill MM, Ma MM, et al. China’s great wall, Israel’s Bar Lev Line, and passive infectious disease surveillance. Mil Med Res 2014; 1: 15.
[184] Minuse E, McQueen JL, Davenport FM, Francis T Jr. Studies of antibodies to 1956 and 1963 equine influenza viruses in horses and man. J Immunol 1965; 94: 563-6.
[185] Masurel N, Mulder J. Studies on the content of antibodies for equine influenza viruses in human sera. Bull World Health Organ 1966; 34(6): 885-93.
[186] Marois P, Pavilanis V, Boudreault A, Di Franco E. An outbreak of type a(2) influenza among horses. Can J Comp Med Vet Sci 1963; 27(11): 257-60.